We are live on ! Find out more
Belvedere Trading

Belvedere Trading Portfolio holdings

AUM $87.6B
1-Year Est. Return 131.08%
This Fund
S&P 500
This Quarter Est. Return
-19.66%
1 Year Est. Return
+131.08%
3 Year Est. Return
+497.29%
5 Year Est. Return
+787.25%
10 Year Est. Return
AUM
$37B
AUM Growth
+$34.1B
Cap. Flow
+$35.7B
Cap. Flow %
96.36%
Top 10 Hldgs %
93.79%
Holding
1,242
New
971
Increased
73
Reduced
63
Closed
119

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 0.27%
2 Healthcare 0.02%
3 Communication Services 0.02%
4 Technology 0.02%
5 Financials 0.01%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ENFY
751
DELISTED
Enlightify Inc
ENFY
$31.2K ﹤0.01%
+7,716
New +$41.2K
PLG
752
Platinum Group Metals
PLG
$176M
$31.1K ﹤0.01%
+17,900
New +$29.6K
BDTX icon
753
Black Diamond Therapeutics
BDTX
$102M
$31.1K ﹤0.01%
+17,295
New +$31.2K
GETY icon
754
CALL
Getty Images
GETY
$200M
$31.1K ﹤0.01%
+5,600
New +$31.3K
VUZI icon
755
CALL
Vuzix
VUZI
$220M
$30.9K ﹤0.01%
+8,500
New +$38.9K
HTZ icon
756
PUT
Hertz
HTZ
$477M
$30.8K ﹤0.01%
+2,000
New +$33.7K
ATCO
757
PUT
DELISTED
Atlas Corp.
ATCO
$30.7K ﹤0.01%
+2,000
New +$30.2K
ADMA icon
758
CALL
ADMA Biologics
ADMA
$2.07B
$30.7K ﹤0.01%
+7,900
New +$24.4K
ASTS icon
759
CALL
AST SpaceMobile
ASTS
$21B
$30.4K ﹤0.01%
+6,300
New +$38K
PGY icon
760
CALL
Pagaya Technologies
PGY
$1.83B
$29.8K ﹤0.01%
+2,000
New +$27.7K
BX icon
761
CALL
Blackstone
BX
$110B
$29.7K ﹤0.01%
+400
New +$34.5K
CBAY
762
DELISTED
Cymabay Therapeutics
CBAY
$29.4K ﹤0.01%
+4,695
New +$17.8K
CNCE
763
DELISTED
Concert Pharmaceuticals, Inc.
CNCE
$29.4K ﹤0.01%
+5,029
New +$26.4K
GOEV
764
CALL
DELISTED
Canoo Inc. Class A Common Stock
GOEV
$29.3K ﹤0.01%
+52
New +$31.9K
NVTA
765
CALL
DELISTED
Invitae Corporation
NVTA
$29.2K ﹤0.01%
+15,700
New +$38.3K
BURU
766
PUT
DELISTED
NUBURU INC
BURU
$29.2K ﹤0.01%
+18
New +$35.7K
VERU icon
767
PUT
Veru
VERU
$38M
$29K ﹤0.01%
550
-4,730
-90% -$389K
SND icon
768
PUT
Smart Sand
SND
$193M
$29K ﹤0.01%
+16,200
New +$30.7K
RSPH icon
769
Invesco S&P 500 Equal Weight Health Care ETF
RSPH
$776M
$28.8K ﹤0.01%
+1,000
New +$27.9K
NTNX icon
770
Nutanix
NTNX
$16.6B
$28.5K ﹤0.01%
+1,095
New +$29.9K
DNA icon
771
CALL
Ginkgo Bioworks
DNA
$612M
$28.2K ﹤0.01%
+418
New +$38.4K
STCN
772
CALL
DELISTED
Steel Connect, Inc. Common Stock
STCN
$28K ﹤0.01%
+2,100
New +$25.9K
IBRX icon
773
CALL
ImmunityBio
IBRX
$7.28B
$27.9K ﹤0.01%
+5,500
New +$30.2K
BIIB icon
774
PUT
Biogen
BIIB
$30.8B
$27.7K ﹤0.01%
+100
New +$28.2K
DM
775
DELISTED
Desktop Metal, Inc.
DM
$27.3K ﹤0.01%
+2,008
New +$41.9K

Similar funds

Belvedere Trading's Q4 2022 Portfolio in Review

As of Q4 2022, Belvedere Trading held 1,242 positions worth $37B, up 1,146% from $2.97B the previous quarter. Its ten largest holdings account for 94% of the portfolio.

Belvedere Trading deployed $35.7B of net new capital in Q4 2022, opening 971 new positions and adding to 73 existing holdings. Its largest new stake was Amazon: 313,766 shares worth $26.4M.

By sector, the portfolio is most concentrated in Consumer Discretionary at 0.27% of assets, down from 0.88% a quarter earlier, followed by Healthcare and Communication Services.

On the sell side, the largest reduction was KraneShares Global Carbon Strategy ETF, an estimated $6.27M trimmed.

  • Belvedere Trading's largest Q4 2022 buy was Amazon: 313,766 shares worth $26.4M.
  • Belvedere Trading added most to Tesla in Q4 2022, an estimated $88.1M increase.
  • Belvedere Trading's biggest Q4 2022 reduction was KraneShares Global Carbon Strategy ETF, cutting an estimated $6.27M.
  • Belvedere Trading fully exited SPDR Gold Trust in Q4 2022, selling an estimated $12.5M.
  • Belvedere Trading's ten largest holdings make up 94% of its $37B portfolio in Q4 2022.
  • Belvedere Trading opened 971 new positions and closed 119 in Q4 2022.
  • Belvedere Trading's portfolio value rose 1,146% quarter-over-quarter to $37B.

Based on Belvedere Trading's 13F filing for Q4 2022, filed 15 Feb 2023.